DIA brings you a symposium with interactive dynamics, where you will engage in discussions with key stakeholders influencing the advancement and implementation of regulatory convergence initiatives in Latin America. Join us to discuss multi-regional cooperation, global harmonization, and best practices related to Latin America’s regulatory landscape.
Sessions will highlight regulatory approaches and good practices to ensure reliance in Latin American and strategic initiatives to improve collaboration and cooperation.
We will be translating:
- English to Spanish and Portuguese
- Spanish to English and Portuguese
- Portuguese to English and Spanish
LETTER TO SUPPORT YOUR US VISA APPLICATION
DIA can provide a letter to confirm your onsite participation as long as you have:
- Already registered for this conference and
- Paid the registration for this conference
To request a confirmation letter please send an email to Megan Stevens at Megan.Stevens@diaglobal.org.
On-Demand Content Preview WebinarThe US FDA Generic Drug Program – The Framework to "Sameness"
Gain an overview of the legal framework for how generic drugs can be developed for approval in the United States, and more.
New Podcast!Promoting Patient-Centric Business: MedComm in Latin America
Hear Barbara Nardi, Associate Director of Medical Communications, PPD, Brazil, and Emanuela Lopes Fernandes Saraiva, Customer Service and Medical Information Manager in Pharmacovigilance, Libbs Farmaceutica, Brazil, discuss topics from DIA's Latin America Medical Information and Communication Workshop.
Who should attend?
Professionals involved in:
- Drug regulation
- Clinical research and development
- Medical and scientific affairs
- Quality assurance
- Research and development
- Strategic sourcing/planning
- Regulatory affairs
At the conclusion of this conference, participants should be able to:
- Discuss various initiatives related to global regulatory convergence and harmonization and their impact on the access of medicines and future R&D in Latin America
- Examine various approaches and best practices to ensure regulatory reliance in Latin America
Mario Alanis • General Director of International Affairs
Federal Commission for the Protection against Sanitary Risks (COFEPRIS), Mexico
Peter Baker • International Relations Specialist, OIP, OGROP
FDA, United States
Maria Guazzaroni Jacobs, PhD • Director Quality and Regulatory Policy (QRP), Pfizer Global Supply
Pfizer Inc, United States
Maria Cristina Mota Pina, MBA • Director, Regulatory Policy and Intelligence -Japan, Emerging Markets and Austra
AbbVie, Inc., United States
Jaime Oliveira, DrPH, AHIP • Head Regulatory Policy and Intelligence LatAm
Bayer S.A., Brazil
Patrícia Oliviera Pereira • Head, Office of International Affairs
Brazilian Health Surveillance Agency - ANVISA, Brazil
Ana Padua, MSc, RPh • Associate Director GRA CMC Regulatory Intelligence Biopharam Global Regulatory
EMD Serono, Switzerland
Ana Patricia Pineda, MSc • International Regulatory Analyst, OIP, OGROP, OC
US FDA, Mexico
Analia Porras • Unit Chief, Medicines and Health Technologies
Pan American Health Organization (PAHO), United States